OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1447
Results
Show all
Save search
Copy query
Show results for
Unknown
(1436)
Proteomics
(8)
Metabolomics
(3)
Organisms
Homo sapiens
(3)
Andropogon gerardi
(3)
Bacteria
(3)
Canis lupus familiaris
(3)
Clostridium perfringens
(3)
Cnidaria
(3)
Cricetulus griseus
(3)
Eukaryota
(3)
Fasciola
(3)
Hepatitis B virus
(3)
Human betaherpesvirus 5
(3)
Japanese encephalitis virus group
(3)
Madurella mycetomatis
(3)
Mesocricetus auratus
(3)
Miscanthus x giganteus
(3)
Mycobacterium tuberculosis
(3)
Orthoflavivirus
(3)
Panicum virgatum
(3)
Platyhelminthes
(3)
Pseudomonas aeruginosa AES-1R
(3)
Rickettsia
(3)
Saccharomyces cerevisiae
(3)
Schizosaccharomyces pombe
(3)
Severe acute respiratory syndrome coronavirus 2
(3)
Shigella
(3)
Sorghastrum nutans
(3)
Streptococcus dysgalactiae subsp. equisimilis SK1249
(3)
Streptococcus pneumoniae
(3)
Mus musculus
(1)
Oryza sativa
(1)
Repository
iProX
(5)
MetaboLights
(3)
pride
(3)
Tissue
Hepatocyte
(1)
Liver
(1)
Stomach
(1)
Stomach lumen
(1)
Disease
Liver cancer
(1)
Stomach carcinoma
(1)
Technology Type
Mass Spectrometry
(3)
Mass spectrometry
(2)
Shotgun proteomics
(2)
Mass spectrometry assay
(1)
Gel-based experiment
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(2)
Liquid Chromatography MS - positive
(1)
Gas Chromatography MS - positive
(1)
Liquid Chromatography MS - positive - reverse phase
(1)
Liquid Chromatography MS - negative - hilic
(1)
Liquid Chromatography MS - positive - hilic
(1)
Publication Date
2026
(3)
2025
(3)
2022
(3)
2020
(1)
2021
(1)
CHEBI ID
CHEBI:39547
(1)
CHEBI:145273
(1)
CHEBI:28300
(1)
Metabolite Name
Sodium Tetradecyl Sulfate
(2)
Taurine
(2)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(1)
Galabiosylceramide (d18:1/26:0);Lactosylceramide (d18:1/26:0)
(1)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0);TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0);TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:1(13Z));TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:1(13Z));TG(22:2(13Z,16Z)/18:1(11Z)/22:2(13Z,16Z));TG(22:2(13Z,16Z)/18:1(9Z)/22:2(13Z,16Z));TG(16:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z));TG(16:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z));TG(16:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z));TG(16:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z));TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0);TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0);TG(18:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z));TG(18:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z));TG(18:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z));TG(18:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z));TG(18:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z));TG(18:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z));TG(18:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z));TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z));TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0);TG(18:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z));TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0);TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0);TG(20:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z));TG(20:0/20:0/22:5(7
(1)
Galabiosylceramide (d18:1/25:0);Lactosylceramide (d18:1/25:0)
(1)
CDP-DG(16:0/18:0);CDP-DG(18:0/16:0)
(1)
Pelargonidin 3-O-[b-D-Glucopyranosyl-(1->2)-[4-hydroxy-3-methoxy-(E)-cinnamoyl-(->6)]-b-D-glucopyranoside] 5-O-(6-O-malonyl-b-D-glucopyranoside)
(1)
Dodecaprenyl diphosphate;PC(DiMe(13,5)/DiMe(13,5))
(1)
Trans-2-Enoyl-OPC6-CoA;(3S)-3-Hydroxy-cis,cis-palmito-7,10-dienoyl-CoA;3-Oxotetradecanoyl-CoA;3-O-alpha-L-Arabinopyranosylcinnamtannin B1
(1)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z));TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z));TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z
(1)
Galabiosylceramide (d18:1/24:0);Lactosylceramide (d18:1/24:0)
(1)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z));TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:4(
(1)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z));TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11
(1)
Galabiosylceramide (d18:1/22:0);Lactosylceramide (d18:1/22:0)
(1)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(1)
Disialosyl galactosyl globoside
(1)
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z));TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z));TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z));TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
(1)
Galabiosylceramide (d18:1/20:0);Lactosylcermide (d18:1/20:0)
(1)
3(S)-Hydroxy-4(R),8-dimethyl-nonanoyl-CoA;Kaempferol 3-O-caffeoyl-sophoroside 7-O-glucoside;Quercetin 3-[p-coumaroyl-(->6)-glucosyl-(1->2)-glucosyl-(1->2)-glucoside]
(1)
PC(DiMe(11,3)/DiMe(13,5));PC(DiMe(11,5)/DiMe(11,5));PC(DiMe(13,5)/DiMe(11,3));PC(DiMe(13,5)/DiMe(9,5));PC(DiMe(9,5)/DiMe(13,5));PC(MonoMe(11,5)/MonoMe(13,5));PC(MonoMe(13,5)/MonoMe(11,5))
(1)
Alliosterol 1-(4''-galactosylrhamnoside) 16-galactoside;Torvoside A;Torvoside B
(1)
Galabiosylceramide (d18:1/20:0);Lactosylcermide (d18:1/20:0);PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z));PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z));PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0);PC(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z));PC(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z));PC(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
(1)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z));PC(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(1)
TG(16:0/24:0/16:0);TG(18:0/20:0/18:0);TG(20:0/16:0/20:0);TG(20:0/18:0/18:0);TG(20:0/20:0/16:0);TG(16:0/20:0/20:0);TG(18:0/18:0/20:0);TG(14:0/18:0/24:0);TG(14:0/20:0/22:0);TG(14:0/22:0/20:0);TG(14:0/24:0/18:0);TG(16:0/16:0/24:0);TG(16:0/18:0/22:0);TG(16:0/22:0/18:0);TG(18:0/14:0/24:0);TG(18:0/16:0/22:0);TG(20:0/14:0/22:0);TG(i-20:0/i-19:0/a-17:0);TG(i-19:0/i-24:0/13:0);TG(i-20:0/i-17:0/i-19:0);TG(i-20:0/19:0/17:0);TG(19:0/a-21:0/i-16:0);TG(i-19:0/22:0/15:0);TG(i-19:0/i-22:0/15:0);TG(20:0/i-19:0/i-17:0);TG(19:0/i-22:0/a-15:0);TG(i-20:0/18:0/18:0);TG(19:0/22:0/15:0);TG(20:0/a-17:0/19:0);TG(i-19:0/i-21:0/16:0);TG(20:0/i-15:0/a-21:0);TG(19:0/22:0/a-15:0);TG(i-20:0/18:0/i-18:0);TG(i-20:0/a-17:0/19:0);TG(i-20:0/i-17:0/19:0);TG(20:0/i-18:0/18:0);TG(20:0/18:0/i-18:0);TG(20:0/i-16:0/i-20:0);TG(19:0/21:0/i-16:0);TG(20:0/17:0/19:0);TG(i-20:0/i-18:0/18:0);TG(i-19:0/a-21:0/16:0);TG(20:0/i-18:0/i-18:0);TG(19:0/i-22:0/i-15:0);TG(i-20:0/17:0/19:0);TG(i-20:0/i-15:0/i-21:0);TG(i-19:0/i-22:0/i-15:0);TG(20
(1)
PI(18:0/22:4(10Z,13Z,16Z,19Z));PI(18:0/22:4(7Z,10Z,13Z,16Z));PI(18:2(9Z,12Z)/22:2(13Z,16Z));PI(20:0/20:3(8Z,11Z,14Z));PI(20:0/20:4(5Z,8Z,11Z,14Z));PI(20:2(11Z,14Z)/20:2(11Z,14Z));PI(20:4(5Z,8Z,11Z,14Z)/20:0);PI(20:4(8Z,11Z,14Z,17Z)/20:0);PI(22:2(13Z,16Z)/18:2(9Z,12Z));PI(22:4(10Z,13Z,16Z,19Z)/18:0);PI(22:4(7Z,10Z,13Z,16Z)/18:0)
(1)
PC(DiMe(11,3)/MonoMe(13,5));PC(DiMe(11,5)/MonoMe(11,5));PC(DiMe(13,5)/MonoMe(11,3));PC(DiMe(13,5)/MonoMe(9,5));PC(DiMe(9,5)/MonoMe(13,5));PC(MonoMe(11,3)/DiMe(13,5));PC(MonoMe(11,5)/DiMe(11,5));PC(MonoMe(13,5)/DiMe(11,3));PC(MonoMe(13,5)/DiMe(9,5));PC(MonoMe(9,5)/DiMe(13,5))
(1)
Galabiosylceramide (d18:1/9Z-18:1);Lactosyceramide (d18:1/18:1(9Z))
(1)
Deltonin;Polypodoside A;beta-Chacotriosyllilagen;Graecunin G;Melongoside H;Diosgenin 3-[glucosyl-(1->4)-rhamnosyl-(1->4)-glucoside]
(1)
PE(22:1(13Z)/24:1(15Z));PE(22:2(13Z,16Z)/24:0);PE(24:0/22:2(13Z,16Z));PE(24:1(15Z)/22:1(13Z))
(1)
Release Date
2025
(258)
2024
(204)
2022
(204)
2023
(181)
2021
(141)
2020
(108)
2019
(67)
2018
(58)
2017
(50)
2026
(44)
2016
(39)
2015
(28)
2014
(22)
2013
(10)
2012
(9)
2011
(5)
2010
(2)
2009
(2)
2006
(2)
2008
(1)
2005
(1)
Lab affiliation
Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen
(1)
Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China
(1)
Department of biochemistry, Zhongshan school of medicine, Sun Yat-sen University,China
(1)
Previous
page
1 / 145
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
145
Next
page
Sort
by:
Relevance
Page size
10
Mechanistic study on the side arm effect in a palladium/Xu-Phos-catalyzed enantioselective alkoxyalkenylation of γ-hydroxyalkenes.
Not available
S-EPMC10665319
|
biostudies-literature
Cite
Visual prognosis and complications of congenital ectopia lentis: study protocol for a hospital-based cohort in Zhongshan Ophthalmic Center.
Not available
S-EPMC10351230
|
biostudies-literature
Cite
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.
Not available
S-EPMC11028303
|
biostudies-literature
Cite
Dynamics in perioperative neutrophil-to-lymphocyte*platelet ratio as a predictor of early acute kidney injury following cardiovascular surgery.
Not available
S-EPMC8260043
|
biostudies-literature
Cite
Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia.
Not available
S-EPMC6329149
|
biostudies-literature
Cite
NKG2A
+
CD8
+
T cells infiltration determines immunosuppressive contexture and inferior response to immunotherapy in clear cell renal cell carcinoma.
Not available
S-EPMC10824007
|
biostudies-literature
Cite
Next-generation sequencing reveals a case of Norrie disease in a child with bilateral ocular malformation.
Not available
S-EPMC9412000
|
biostudies-literature
Cite
Electrolyte and acid-base disorders in cancer patients and its impact on clinical outcomes: evidence from a real-world study in China.
Not available
S-EPMC7067195
|
biostudies-literature
Cite
Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma.
Not available
S-EPMC11014826
|
biostudies-literature
Cite
<i>VHL</i> missense mutation delineate aggressive clear cell renal cell carcinoma subtype with favorable immunotherapeutic response.
Not available
S-EPMC11499804
|
biostudies-literature
Cite
Previous
page
1 / 145
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
145
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
